Log in
Enquire now
‌

US Patent 7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system

Patent 7531326 was granted and assigned to Intrexon Corporation on May, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
‌
Intrexon Corporation
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
75313260
Patent Inventor Names
Marianna Zinovjevna Kapitskaya0
Subba Reddy Palli0
Date of Patent
May 12, 2009
0
Patent Application Number
104681990
Date Filed
February 20, 2002
0
Patent Citations Received
‌
US Patent 12060585 Expression of novel cell tags
0
Patent Primary Examiner
‌
Manjunath Rao
0
Patent abstract

This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel ecdysone receptor/chimeric retinoid X receptor-based inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation traits in transgenic organisms.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.